Nom du produit:6-Cyclobutylpyridazin-3(2H)-one

IUPAC Name:6-cyclobutyl-2,3-dihydropyridazin-3-one

CAS:1161737-37-6
Formule moléculaire:C8H10N2O
Pureté:95%
Numéro de catalogue:CM316729
Poids moléculaire:150.18

Unité d'emballage Stock disponible Prix($) Quantité
CM316729-1g 1-2 Weeks ƻșǕ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1161737-37-6
Formule moléculaire:C8H10N2O
Point de fusion:-
Code SMILES:O=C1C=CC(C2CCC2)=NN1
Densité:
Numéro de catalogue:CM316729
Poids moléculaire:150.18
Point d'ébullition:
N° Mdl:MFCD11520596
Stockage:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.